XLY Auxly Cannabis Group Inc.

2.440USD3.490 CAD · TSX-1.13%Mkt Cap: 251.86M USDP/E: 15.86

Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. The company offers dried and fresh cannabis, plants, seeds, and oils; and edibles, extracts, and topicals…

Insiders, last 90 days6 buys
Institutional holders2 on file

Key Statistics

Company
Market Cap251.86M USD
Enterprise Value251.12M USD
Revenue (TTM)122.44M USD
Gross Profit60.64M USD
Net Income (TTM)29.26M USD
Revenue/Share1.22 USD
Last Price2.440 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees446
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA05335P1099
Valuation
P/E (Trailing)15.86
P/E (Forward)13.73
PEG—
EV/EBITDA9.01
EV/Revenue2.05
P/S2.06
P/B1.85
EPS (TTM)0.15 USD
EPS (Forward)0.18 USD
52W Range
1.07783% of range2.719
52W High2.719 USD
52W Low1.077 USD
Profitability
Gross Margin57.26%
Oper. Margin17.29%
EBITDA Margin22.76%
Profit Margin27.63%
ROE23.57%
ROA15.41%
ROIC16.11%
ROCE14.42%
Growth
Revenue Growth24.00%
Earnings Growth-33.30%
Cash Flow & Leverage
Operating CF18.31M USD
CapEx (TTM)1.76M USD
FCF Margin20.11%
FCF Yield9.78%
Net Debt892.68K USD
Net Debt/EBITDA0.03
Net Debt/FCF0.04
Balance Sheet
Debt/Equity0.32
Current Ratio2.38
Quick Ratio1.52
Book Value/Sh1.32 USD
Cash/Share0.35 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:14
Split DateJul 28, 2026
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)3.495 USD
Upside (mean)+43.3%
Target Range3.146 USD – 3.845 USD
3.146+43.3% to mean3.845
# Analysts2
Ownership
Shares Out.103.24M
Float78.09M
Insiders23.09%
Institutions0.56%
Short Interest
Short Ratio7.5d
Short % Out.0.71%
Shares Short735.46K
Short (prev mo.)658.27K
Technical
SMA 502.433 (+0.3%)
SMA 2001.777 (+37.3%)
Beta1.25
S&P 52W Chg12.00%
Avg Vol (30d)118.84K
Avg Vol (10d)166.21K
Technical Indicators
RSI (14)48.9
MACD0.0323
MACD Signal0.0483
MACD Hist.-0.0161
BB Upper2.634 USD
BB Middle2.485 USD
BB Lower2.336 USD
BB Width11.99%
ATR (14)0.1089 USD
Vol Ratio (20d)0.95x

About Auxly Cannabis Group (TSE: XLY)

›

Auxly Cannabis Group (TSE: XLY) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 446 employees.

The shares were at 3.490 CAD on 19 November 2026, up 60.8% over 52 weeks. Its 52-week range is 1.540 CAD to 3.890 CAD: the price is 10.3% below the high and 126.6% above the low.

At a market capitalisation of 360.29M CAD, it trades at 15.9 times trailing earnings and 13.7 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, a discount of 36% for XLY.

Auxly Cannabis Group reports return on equity of 23.6%, an operating margin of 17.3% and revenue up 24.0% year over year.

Its debt exceeds its cash by 1.28M CAD, a debt-to-equity ratio of 0.32. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 2 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 5.000 CAD is 43.3% above the current price. The next earnings report is expected on 25 March 2027.